SAN DIEGO, Nov. 17, 2014 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today it will be participating in the Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 20.
The presentation by John Dahldorf, chief financial officer, will begin at 3 p.m., Eastern Standard Time (12 p.m., Pacific Standard Time). The presentation will be available through the conference website at http://www.wsw.com/webcast/canaccord16/volc and via the company's website at www.volcanocorp.com.
About Volcano Corporation
Through its multi-modality platform, Volcano Corporation is the global leader in intravascular imaging for coronary and peripheral therapeutic devices. The company's broad range of technologies makes imaging and therapy simpler, more informative and less invasive and offers physicians and their patients around the world with industry-leading tools that aid diagnosis and guide and provide therapy. Founded in cardiovascular care and expanding into other specialties, Volcano is focused on improving patient and economic outcomes. For more information, visit the company's website at www.volcanocorp.com
SOURCE Volcano Corporation